Nektar Therapeutics (NKTR) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to -$7.2 million.
- Nektar Therapeutics' Other Gross PP&E Adjustments rose 2000.22% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year increase of 2000.22%. This contributed to the annual value of -$28.3 million for FY2024, which is 2596.29% up from last year.
- Latest data reveals that Nektar Therapeutics reported Other Gross PP&E Adjustments of -$7.2 million as of Q3 2025, which was up 2000.22% from -$7.6 million recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Other Gross PP&E Adjustments registered a high of $110.4 million during Q2 2022, and its lowest value of -$125.0 million during Q1 2021.
- Over the past 5 years, Nektar Therapeutics' median Other Gross PP&E Adjustments value was -$19.2 million (recorded in 2023), while the average stood at -$27.3 million.
- Over the last 5 years, Nektar Therapeutics' Other Gross PP&E Adjustments had its largest YoY gain of 19018.49% in 2022, and its largest YoY loss of 27829.41% in 2022.
- Quarter analysis of 5 years shows Nektar Therapeutics' Other Gross PP&E Adjustments stood at $43.8 million in 2021, then plummeted by 278.29% to -$78.1 million in 2022, then soared by 51.08% to -$38.2 million in 2023, then rose by 25.96% to -$28.3 million in 2024, then soared by 74.64% to -$7.2 million in 2025.
- Its last three reported values are -$7.2 million in Q3 2025, -$7.6 million for Q2 2025, and -$8.0 million during Q1 2025.